Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine and docetaxel in patients with recurrent osteosarcoma, Ewing's sarcoma, or unresectable/locally recurrent chondrosarcoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma
• Ewing Sarcoma
• Osteosarcoma

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)
• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2012-03-12